ATE219372T1 - Verfahren zur behandlung von blutungsstorungen - Google Patents

Verfahren zur behandlung von blutungsstorungen

Info

Publication number: ATE219372T1
Authority: AT; Austria
Prior art keywords: treating; vwd; bleeding disorders; von willebrand; congenital
Prior art date: 1994-07-22

Application number

AT95917218T

Other languages

English (en)

Inventor

James A Kaye

Original Assignee

Genetics Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-22

Filing date

1995-04-27

Publication date

2002-07-15

1995-04-27 Application filed by Genetics Inst filed Critical Genetics Inst

2002-07-15 Application granted granted Critical

2002-07-15 Publication of ATE219372T1 publication Critical patent/ATE219372T1/de

Links

238000000034 method Methods 0.000 title abstract 4
230000000740 bleeding effect Effects 0.000 title abstract 2
208000027276 Von Willebrand disease Diseases 0.000 abstract 4
208000012137 von Willebrand disease (hereditary or acquired) Diseases 0.000 abstract 4
206010010356 Congenital anomaly Diseases 0.000 abstract 2
208000037157 Azotemia Diseases 0.000 abstract 1
102100026735 Coagulation factor VIII Human genes 0.000 abstract 1
201000003542 Factor VIII deficiency Diseases 0.000 abstract 1
206010016654 Fibrosis Diseases 0.000 abstract 1
208000009292 Hemophilia A Diseases 0.000 abstract 1
208000032843 Hemorrhage Diseases 0.000 abstract 1
208000024659 Hemostatic disease Diseases 0.000 abstract 1
101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 abstract 1
230000007882 cirrhosis Effects 0.000 abstract 1
208000019425 cirrhosis of liver Diseases 0.000 abstract 1
230000007547 defect Effects 0.000 abstract 1
208000031169 hemorrhagic disease Diseases 0.000 abstract 1
208000004521 platelet storage pool deficiency Diseases 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
238000001356 surgical procedure Methods 0.000 abstract 1
208000009852 uremia Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2073—IL-11
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)
Soy Sauces And Products Related Thereto (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT95917218T 1994-07-22 1995-04-27 Verfahren zur behandlung von blutungsstorungen ATE219372T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/278,765 US5582821A (en)	1994-07-22	1994-07-22	Methods for treating bleeding disorders
PCT/US1995/005439 WO1996003143A1 (en)	1994-07-22	1995-04-27	Methods for treating bleeding disorders

Publications (1)

Publication Number	Publication Date
ATE219372T1 true ATE219372T1 (de)	2002-07-15

Family

ID=23066267

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95917218T ATE219372T1 (de)	1994-07-22	1995-04-27	Verfahren zur behandlung von blutungsstorungen

Country Status (10)

Country	Link
US (1)	US5582821A (de)
EP (1)	EP0772450B1 (de)
JP (1)	JPH10503195A (de)
AT (1)	ATE219372T1 (de)
AU (1)	AU2381795A (de)
DE (1)	DE69527145T2 (de)
DK (1)	DK0772450T3 (de)
ES (1)	ES2177646T3 (de)
PT (1)	PT772450E (de)
WO (1)	WO1996003143A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPO439396A0 (en)	1996-12-24	1997-01-23	Walter And Eliza Hall Institute Of Medical Research, The	A method of treatment and prophylaxis
US6953777B2 (en) *	1999-03-11	2005-10-11	Genetics Indtitute LLC	Use of interleukin-11 to prevent immune-mediated cytotoxicity
MXPA02000525A (es) *	1999-07-15	2005-07-01	Inst Genetics Llc	Formulaciones de il-11.
WO2003049693A2 (en) *	2001-12-06	2003-06-19	Wyeth	Method and composition for inducing weight loss
US9788539B2 (en)	2011-05-17	2017-10-17	Velico Medical, Inc.	Platelet protection solution having beta-galactosidase and sialidase inhibitors
CA2835434A1 (en)	2011-05-17	2012-11-22	Velico Medical, Inc.	Improved platelet storage using a sialidase inhibitor
WO2014055988A1 (en)	2012-10-05	2014-04-10	Velico Medical, Inc.	Platelet additive solution having a beta-galactosidase inhibitor
WO2014120886A1 (en)	2013-01-30	2014-08-07	Velico Medical, Inc.	Platelet additive solution having a self-assembling hydrogel-forming peptide
US20150160214A1 (en) *	2013-12-05	2015-06-11	Mayo Foundation For Medical Education And Research	Quantitation of Cellular Adhesion Dynamics Across Immobilized Receptors Under Rheological Shear Flow
WO2022180145A2 (en)	2021-02-26	2022-09-01	Bayer Aktiengesellschaft	Inhibitors of il-11 or il-11ra for use in the treatment of abnormal uterine bleeding

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4518584A (en) *	1983-04-15	1985-05-21	Cetus Corporation	Human recombinant interleukin-2 muteins
US5215895A (en) *	1989-11-22	1993-06-01	Genetics Institute, Inc.	Dna encoding a mammalian cytokine, interleukin-11
CA2089553C (en) *	1990-08-29	2000-06-27	Paul Schendel	Multidomain hematopoiesis stimulators
US5292646A (en) *	1991-02-06	1994-03-08	Genetics Institute, Inc.	Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5270181A (en) *	1991-02-06	1993-12-14	Genetics Institute, Inc.	Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
EP0560998A4 (en) *	1991-10-09	1993-12-01	Toray Industries, Inc.	Medicine for preventing and treating bleeding tendency

1994
- 1994-07-22 US US08/278,765 patent/US5582821A/en not_active Expired - Lifetime
1995
- 1995-04-27 AT AT95917218T patent/ATE219372T1/de not_active IP Right Cessation
- 1995-04-27 PT PT95917218T patent/PT772450E/pt unknown
- 1995-04-27 JP JP8505717A patent/JPH10503195A/ja active Pending
- 1995-04-27 DE DE69527145T patent/DE69527145T2/de not_active Expired - Fee Related
- 1995-04-27 DK DK95917218T patent/DK0772450T3/da active
- 1995-04-27 AU AU23817/95A patent/AU2381795A/en not_active Abandoned
- 1995-04-27 ES ES95917218T patent/ES2177646T3/es not_active Expired - Lifetime
- 1995-04-27 EP EP95917218A patent/EP0772450B1/de not_active Expired - Lifetime
- 1995-04-27 WO PCT/US1995/005439 patent/WO1996003143A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO1996003143A1 (en)	1996-02-08
ES2177646T3 (es)	2002-12-16
DE69527145D1 (de)	2002-07-25
DK0772450T3 (da)	2003-04-14
EP0772450B1 (de)	2002-06-19
DE69527145T2 (de)	2003-02-13
JPH10503195A (ja)	1998-03-24
AU2381795A (en)	1996-02-22
EP0772450A1 (de)	1997-05-14
PT772450E (pt)	2002-10-31
US5582821A (en)	1996-12-10

Similar Documents

Publication	Publication Date	Title
ATE66374T1 (de)	1991-09-15	Zubereitungen und verfahren zur behandlung von blutungsstoerungen.
DE69625691D1 (de)	2003-02-13	Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
DE69428905D1 (de)	2001-12-06	Aktivierter faktor viii als ein therapeutisches mittel und verfahren zur behandlung eines faktor viii mangels
DE69535264D1 (de)	2006-11-23	Verfahren zur behandlung von diabetes mittels kgf
DE59807122D1 (de)	2003-03-13	Verwendung von fumarsäurederivaten zur behandlung von autoimmunerkrankungen
DE69521623D1 (de)	2001-08-09	Zusammensetzung für die stabilisation von zahnprothesen
DE69333286D1 (de)	2003-12-11	Eine thrombin-blutfraktion zur verwendung in einem medizinischen verfahren
DE59407237D1 (de)	1998-12-10	Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems
ATE225176T1 (de)	2002-10-15	Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
DE69521700D1 (de)	2001-08-16	Mittel und methoden zur behandlung von plaque-krankheiten
ATE22657T1 (de)	1986-10-15	Prostaglandin e1, enthaltende emulsion und verfahren zu ihrer herstellung.
DE69527145D1 (de)	2002-07-25	Verfahren zur behandlung von blutungsstorungen
DE69029100D1 (de)	1996-12-19	Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgaris
DE58906574D1 (de)	1994-02-10	Verfahren zur Herstellung von cyclischen Kohlensäureestern.
NO995843D0 (no)	1999-11-29	Farmasöytisk preparat omfattende vWF-propeptid
ATE164065T1 (de)	1998-04-15	Neues verfahren zur behandlung von depression
DE60035693D1 (de)	2007-09-06	Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ATE25690T1 (de)	1987-03-15	Gerinnungsaktive plasmaproteinloesung, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von stoerungen des haemostasesystems.
DE69327314D1 (de)	2000-01-20	Zusammensetzungen enthaltend Lipoprotein-Associated-Coagulation-Inhibitor (LACI) zur Herstellung eines Medikaments zur Behandlung von akuten oder chronischen Enzündungen
ATE430578T1 (de)	2009-05-15	Faktor viii oder von willebrand faktor zur behandlung von thrombopathie assoziierenden hämorrhagischen erkrankungen
ATE114468T1 (de)	1994-12-15	Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.
US4191751A (en)	1980-03-04	Method for promoting growth of new connective tissue over surface wounds
DE3865484D1 (de)	1991-11-21	Verfahren zur herstellung von urantetrafluorid und von schwefelfluoriden mittels redoktion von uranhexafluorid.
DE60041266D1 (de)	2009-02-12	Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
DE69331193D1 (de)	2002-01-03	Verfahren und zusammensetzungen zur verhinderung von entzündungen, die durch endothelzellen und fibrinogen ausgelöst werden

Legal Events

Date

Code

Title

Description

2003-03-15

UEP

Publication of translation of european patent specification

Ref document number: 0772450

Country of ref document: EP

2008-01-15

REN

Ceased due to non-payment of the annual fee